Article
Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon‐alfa and ribavirin†
12 Jan 2009
Abstract excerpt
UNLABELLED: Responsiveness to hepatitis C virus (HCV) therapy depends on viral and host factors. Our aim was to assess sustained virologic response (SVR)-associated early gene expression in patients with HCV receiving pegylated interferon-alpha2a (PEG-IFN-alpha2a) or PEG-IFN-alpha2b and ribavirin with the duration based on genotypes. Blood samples were collected into PAXgene tubes prior to treatment as well as 1,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
